Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Prevalence in the USA of rilpivirine resistance-associated mutations in clinical samples and effects on phenotypic susceptibility to rilpivirine and etravirine.

Picchio GR, Rimsky LT, Van Eygen V, Haddad M, Napolitano LA, Vingerhoets J.

Antivir Ther. 2014;19(8):819-23. doi: 10.3851/IMP2771. Epub 2014 Apr 4.

PMID:
24704709
2.

Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trial.

Benhamou Y, Moussalli J, Ratziu V, Lebray P, De Backer K, De Meyer S, Ghys A, Luo D, Picchio GR, Beumont M.

J Infect Dis. 2013 Sep;208(6):1000-7. doi: 10.1093/infdis/jit274. Epub 2013 Jun 24.

PMID:
23801602
3.

Prevalence of hepatitis C virus antibody in newborn infants in southern California in 2003.

Bradley JS, Graham S, Picchio GR, Vugia DJ, Kharrazi M.

Pediatr Infect Dis J. 2011 Jul;30(7):618-20. doi: 10.1097/INF.0b013e318214dc4d.

PMID:
21394051
4.

Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs).

Kieffer TL, Kwong AD, Picchio GR.

J Antimicrob Chemother. 2010 Feb;65(2):202-12. doi: 10.1093/jac/dkp388. Epub 2009 Nov 10. Review.

PMID:
19903720
5.

High prevalence of infection with a single hepatitis C virus genotype in a small rural community of Argentina.

Picchio GR, Baré PC, Descalzi VI, Bussy MV, Soria SM, Raffa MP, Mazzencio NE, Etchehun S, Cámera JA, Mosier DE, Villamil FG.

Liver Int. 2006 Aug;26(6):660-5.

PMID:
16842321
6.

Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES.

Pastore C, Picchio GR, Galimi F, Fish R, Hartley O, Offord RE, Mosier DE.

Antimicrob Agents Chemother. 2003 Feb;47(2):509-17.

7.

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.

Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM.

J Virol. 2003 Feb;77(3):2134-46.

8.

Decreased recovery of replication-competent HIV-1 from peripheral blood mononuclear cell-derived monocyte/macrophages of HIV-positive patients after 3 years on highly active antiretroviral therapy.

Belmonte L, Baré P, Picchio GR, Perez Bianco R, de Tezanos Pinto M, Corti M, Villafañe MF, de Bracco MM, Ruibal-Ares BH.

AIDS. 2002 Jun 14;16(9):1289-92.

PMID:
12045497
9.

Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.

Sabbe R, Picchio GR, Pastore C, Chaloin O, Hartley O, Offord R, Mosier DE.

J Virol. 2001 Jan;75(2):661-71.

10.

Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy.

Picchio GR, Valdez H, Sabbe R, Landay AL, Kuritzkes DR, Lederman MM, Mosier DE.

J Acquir Immune Defic Syndr. 2000 Dec 1;25(4):289-95.

PMID:
11114828
11.

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR.

Immunity. 1999 Apr;10(4):431-8.

12.

Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.

Mosier DE, Picchio GR, Gulizia RJ, Sabbe R, Poignard P, Picard L, Offord RE, Thompson DA, Wilken J.

J Virol. 1999 May;73(5):3544-50.

13.

The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Picchio GR, Gulizia RJ, Wehrly K, Chesebro B, Mosier DE.

J Virol. 1998 Mar;72(3):2002-9. Erratum in: J Virol 1998 Sep;72(9):7707.

14.
16.

Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.

Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Pérez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D.

J Med Virol. 1997 Jun;52(2):219-25.

PMID:
9179772
17.

HTLV-I/II indeterminate serology and natural killer cell expansion.

Picchio GR, Bare P, Savignano R, Perez-Bianco R, Yamashita M, Hayami M.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):428-31. No abstract available.

PMID:
8673555
20.

Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.

Mosier DE, Picchio GR, Baird SM, Kobayashi R, Kipps TJ.

Cancer Res. 1992 Oct 1;52(19 Suppl):5552s-5553s.

21.

EBV-induced human B cell lymphomas in hu-PBL-SCID mice.

Mosier DE, Picchio GR, Kirven MB, Garnier JL, Torbett BE, Baird SM, Kobayashi R, Kipps TJ.

AIDS Res Hum Retroviruses. 1992 May;8(5):735-40. Review.

PMID:
1325170
22.
23.

Impaired response to alloantigens in HIV positive hemophilic patients.

Soria AG, Picchio GR, Bouzas MB, Muchinik GR, Anselmo A, Perez Bianco R, de Bracco MM, Ruibal-Ares BH.

Haematologica. 1989 May-Jun;74(3):255-61.

PMID:
2531112
24.

HIV isolations in Argentina.

Picchio GR, Muchinik GR, Bouzas MB, Rickard E, Soria A, Ruibal Ares B, Perez Bianco R, Anselmo A, de Tezanos Pinto M, Perez H, et al.

AIDS. 1988 Jun;2(3):228-9. No abstract available.

PMID:
3134922
25.

[Evaluation of indirect immunofluorescence as a confirmatory assay in the serologic diagnosis of infection by human immunodeficiency virus (HIV)].

Picchio GR, Muchinik GR.

Medicina (B Aires). 1988;48(2):120-4. Spanish. No abstract available.

PMID:
3068476
26.

Anti-class II antibodies in AIDS patients and AIDS-risk groups.

de la Barrera S, Fainboim L, Lugo S, Picchio GR, Muchinik GR, de Bracco MM.

Immunology. 1987 Dec;62(4):599-604.

27.

Prevalence of HIV antibodies in hemophiliacs in Buenos Aires.

Muchinik GR, Anselmo AA, Picchio GR, Livellara B, Martín E, Bouzas MB, Pérez Bianco R, de Tezanos Pinto M.

Medicina (B Aires). 1987;47(4):367-70. No abstract available.

PMID:
3452726

Supplemental Content

Loading ...
Support Center